Document is current
Any future updates will be listed below
-
Authors
Bernardo-Colón, Alexandra https://orcid.org/0009-0009-0772-8225
Bighinati, Andrea https://orcid.org/0000-0002-7584-1934
Parween, Shama https://orcid.org/0000-0001-8440-2055
Debnath, Subrata https://orcid.org/0000-0003-3858-8367
Piano, Ilaria https://orcid.org/0000-0002-5073-7583
Adani, Elisa https://orcid.org/0000-0001-5294-0270
Corsi, Francesca https://orcid.org/0000-0002-9350-7948
Gargini, Claudia https://orcid.org/0000-0002-4992-9086
Vergara, Natalia https://orcid.org/0000-0003-4545-8181
Marigo, Valeria https://orcid.org/0000-0002-4428-2084
Patricia Becerra, S. https://orcid.org/0000-0001-8004-4983
- License Information
-
More Information
Article History
Received: 26 June 2024
Accepted: 27 February 2025
First Online: 21 March 2025
Competing interests
: US Government and University of Modena and Reggio Emilia, Italy. S. P. Becerra, A. Bernardo-Colón, V. Marigo, A Bighinati. US Application No. 63 430 251 NIH Ref No E-028-2023-0-US-01 and international application PCT/US2023/064947, filed on March 24, 2023. The specific aspect of the manuscript covered in the patent applications is on PIGMENT EPITHELIUM-DERIVED FACTOR PEPTIDES AND USE FOR TREATING RETINAL DEGENERATION.
